New method may help predict platelet transfusion risk in infants
Researchers developed a statistical model that could help clinicians make platelet transfusion decisions for infants with thrombocytopenia.
Researchers developed a statistical model that could help clinicians make platelet transfusion decisions for infants with thrombocytopenia.
Learn more about the difference between FNAIT caused by HPA-5b versus HPA-1a antibodies, including prevalence, disease severity and more.
A recent study found that a minimally invasive neurosurgical procedure can treat intraventricular hemorrhage (IVH), a complication of FNAIT.
A study of genetic data from the Saudi population found that the predicted risk of FNAIT does not always align with observed outcomes.
Learn more about the difference between FNAIT caused by HPA-5b vs HPA-1a antibodies, including prevalence, treatment options and more.
Scientists developed a new technique to detect platelet antigens linked to FNAIT and quantify fetal DNA in maternal blood samples.
Researchers in Norway called for countries to update their guidelines to include consideration of anti-HPA-1a levels when treating FNAIT.
A study presents six cases of pregnant women with severe ITP, highlighting the importance of individualized treatment to improve outcomes.
Prednisone is sometimes prescribed as a treatment for FNAIT, but in some patients, it can lead to gestational diabetes.
In areas where the MAIPA test is unavailable, platelet crossmatching can be a useful tool for diagnosing FNAIT.